C4 Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from C4 therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In C4 Therapeutics Today - Breaking & Trending Today

C4 Therapeutics (NASDAQ:CCCC) Stock Rating Reaffirmed by Stifel Nicolaus

C4 Therapeutics (NASDAQ:CCCC – Get Free Report)‘s stock had its “buy” rating reissued by Stifel Nicolaus in a research report issued to clients and investors on Friday, Benzinga reports. They currently have a $13.00 target price on the stock, up from their previous target price of $12.00. Stifel Nicolaus’ target price would suggest a potential […] ....

Stifel Nicolaus , Stifel Nicolau , Jpmorgan Chase Co , Therapeutics Inc , Morgan Stanley , Get Free Report , State Street Corp , Street Corp , C4 Therapeutics , Nasdaq Cccc , Reiterated Rating ,

C4 Therapeutics, Inc. (NASDAQ:CCCC) Receives $9.78 Average PT from Brokerages

Shares of C4 Therapeutics, Inc. (NASDAQ:CCCC – Get Free Report) have been given an average rating of “Hold” by the seven research firms that are presently covering the stock, MarketBeat.com reports. Four analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 1 year […] ....

Stifel Nicolaus , Therapeutics Company Profile , Arrowmark Colorado Holdings , Morgan Stanley , Jpmorgan Chase Co , Therapeutics Inc , Get Free Report , Street Corp , Mark Colorado Holdings , Get Free , C4 Therapeutics , Nasdaq Cccc ,

Analysts Offer Predictions for C4 Therapeutics, Inc.'s FY2028 Earnings (NASDAQ:CCCC)

C4 Therapeutics, Inc. (NASDAQ:CCCC – Free Report) – Equities researchers at Brookline Capital Management issued their FY2028 earnings estimates for shares of C4 Therapeutics in a research note issued to investors on Tuesday, January 9th. Brookline Capital Management analyst L. Cann anticipates that the company will post earnings per share of $47.11 for the year. […] ....

United States , Stifel Nicolaus , Citigroup Inc , Tower Research Capital , Morgan Stanley , Tudor Investment Corp Et Al , Therapeutics Company Profile , Therapeutics Inc , Free Report , Brookline Capital Management , Capital Management , Get Free Report , Research Capital , Point Capital Management , Pale Fire Capital , C4 Therapeutics , Nasdaq Cccc , Earnings Estimates ,

Reviewing ZIVO Bioscience (NASDAQ:ZIVO) and C4 Therapeutics (NASDAQ:CCCC)

C4 Therapeutics (NASDAQ:CCCC – Get Free Report) and ZIVO Bioscience (NASDAQ:ZIVO – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and valuation. Risk and Volatility C4 Therapeutics has a […] ....

United States , Bloomfield Hills , Bioscience Inc , Roche Inc , Calico Life Sciences , Biogen Ma Inc , Health Enhancement Products Inc , Roche Ltd , Therapeutics Inc , Get Free Report , Hoffmann La Roche Inc , Health Enhancement Products , C4 Therapeutics , Nasdaq Cccc , Stock Comparison , Stock Analysis ,

C4 Therapeutics Shares Rise 13% After Restructuring, Layoffs

By Chris Wack C4 Therapeutics shares were up 13% at $8.22 after the company started to restructure, including making layoffs, to extend its cash runway. The. ....

Chris Wack , Betta Pharmaceuticals , Article Normal , Biotechnology Services , Healthcare Life Sciences , Air Transport , Biological Therapy , Specialized Drugs Medications , Healthcare Provision , Transportation Logistics , Corporate Strategy Planning , Financial Performance , Share Price Movement Disruptions , Labor Personnel , Corporate Industrial News , Corporate Organizational Restructuring , Lay Offs Redundancies , Equity Markets , Commodity Financial Market News , Content Types , Factiva Filters , C Amp Ampe Exclusion Filter , C Amp Ampe Industry News Filter , Betta Pharmaceuticals Co Ltd A , 300558 Sz , Cn 300558 ,